Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Brenda Fitzgerald, the embattled director of the Centers for Disease Control and Prevention, has resigned. Fitzgerald has consistently faced questions about financial conflicts of interest, and those questions intensified yesterday after Politico reported that she had purchased stock in tobacco companies after taking the helm at the country's top public health agency.
Why it matters: Fitzgerald is the second high-profile health official to step down in roughly the first year of the Trump administration. Health and Human Services secretary Tom Price resigned last year over his use of private jets.
Anne Schuchat, the CDC's principal deputy director, is filling in as acting director while the administration searches for a permanent replacement.